You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,800,481


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,800,481
Title: HINGE TYPE UNITS PERMANENTLY MOUNTED IN A CYLINDRICAL HUB STRUCTURE WITH REPLACEABLE FINISHING PACKS PROVIDED FOR THE UNITS
Abstract:The rotary flap or finishing wheel or tool has a plurality of radially extending finishing units or packs mounted in a circumferential series on a hub structure. The finishing units are mounted on the body structure by a dual clip-type assembly including an inner axially elongated and rigid clip member forming the primary component of the pack and an axially elongated outer clip member supporting or carrying the finishing or fill material and forming the secondary components of the finishing unit. The mount of the inner clip member is afforded at an inner axially extending through-bore therein which encircles an axial pin component located adjacent the outer periphery of the hub structure. The inner clip member has an axially elongated, keyhole-type slot or groove that opens re-entrantly along the entire axial length of the outer free clip end. Replaceable units of fill or finishing material are each constituted in part by the secondary or outer clip component or member having radial arms which are coextensive in axial length with the finishing material and are stapled in place within the latter. The arms integrally connect with one another at a radially inner bight at which, along with a telescoped inner wear sleeve, the pre-assembled finishing unit-secondary clip member -- is telescoped into the re-entrant keyhole recess of the primary clip member. Either one or both of the clip members of each finishing unit are mounted for pivotal movement.
Inventor(s): Belanger; James A. (Livonia, MI)
Assignee: Belanger, Inc. (Northville, MI)
Application Number:05/253,237
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 3,800,481: A Detailed Analysis

Introduction

United States Patent 3,800,481, though an older patent, provides a valuable case study for understanding the evolution and current landscape of patent law, particularly in the context of technological innovations. This analysis will delve into the key aspects of this patent, including its claims, the patentability criteria, and how it fits into the broader patent landscape.

Background of the Patent

To begin, it is essential to understand the historical context and the subject matter of the patent. United States Patent 3,800,481 was granted in 1974, a time when patent laws and technological advancements were significantly different from today. The patent would have been evaluated under the patentability criteria of its time, which included novelty, nonobviousness, and usefulness[5].

Claims and Scope

The claims of a patent define the scope of the invention and are crucial for determining what is protected under the patent. Here are some key points to consider:

Claim Structure

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The structure and language of these claims are critical in defining the patent's scope[3].

Patent Scope Metrics

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. These metrics can indicate the breadth and clarity of the patent claims, which in turn affect the patent's validity and the ease of the examination process[3].

Patentability Criteria

For a patent to be granted, the invention must meet specific criteria:

Novelty

The invention must be new and not obvious to someone with ordinary skill in the relevant field. This criterion ensures that the patent is granted for something that is truly innovative[5].

Nonobviousness

The invention must be significantly different from existing technology and not obvious to someone with ordinary skill in the field. This is a critical test to ensure that the invention is not just a minor improvement but a substantial advancement[5].

Usefulness

The invention must have a practical application and be useful. This ensures that the patent is granted for something that has real-world value[5].

Current Patent Landscape and AI

In the modern context, especially with the rise of artificial intelligence (AI), the patent landscape has evolved significantly.

AI and Patent Eligibility

The recent USPTO guidance update on AI patent eligibility highlights key changes in how AI-related inventions are evaluated. The update emphasizes the integration of judicial exceptions into practical applications and the importance of demonstrating concrete technological improvements. This means that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution and the claimed invention offers tangible benefits[1].

Examples and Case Law

The USPTO has provided new examples specifically tailored to AI technologies, illustrating how claims involving AI can meet patent eligibility criteria. For instance, Example 48 shows how a claim involving an AI method can be patent-eligible if it specifies a practical application that enhances technology, such as improving the accuracy of speech recognition systems[1].

Impact of Recent Judicial and Administrative Developments

Recent judicial and administrative developments have significantly influenced the standards for determining patent-eligible subject matter.

Section 101 of the Patent Act

Section 101 sets out the categories of patentable inventions, but judicial exceptions have narrowed the scope of patent-eligible subject matter. The Supreme Court's decisions in cases like Bilski, Mayo, and Association for Molecular Pathology have broadened these exceptions, affecting the patentability of certain types of inventions[2].

Alice/Mayo Test

The Alice/Mayo test is a two-step framework used to determine patent eligibility. It involves assessing whether the claims are directed to an ineligible concept and, if so, whether the claims include additional elements that transform the concept into patent-eligible subject matter. This test has been pivotal in evaluating the patentability of software-related and AI inventions[2].

Practical Implications for Innovators and Practitioners

Understanding the scope and claims of a patent, especially in the context of current legal and technological developments, is crucial for innovators and practitioners.

Drafting Claims

Practitioners must draft claims that integrate judicial exceptions into practical applications, ensuring that the claimed invention offers concrete technological improvements. This involves careful analysis and the inclusion of specific examples that demonstrate the practical application of the invention[1].

Patent Prosecution

The patent prosecution process can be complex and time-consuming. Innovators and practitioners must be prepared to argue and amend claims to overcome rejections. The use of recent case law and examples provided by the USPTO can aid in this process[5].

International Patent Considerations

For inventions with global potential, understanding international patent laws and procedures is essential.

PCT Applications

International patent applications under the Patent Cooperation Treaty (PCT) allow applicants to preserve the right to file patents in multiple countries. This process can be costly but provides a unified procedure for seeking patent protection in many jurisdictions[5].

Conclusion

Understanding the scope and claims of a patent like United States Patent 3,800,481 requires a deep dive into the historical context, patentability criteria, and current legal and technological developments.

  • Historical Context: Patents granted in the past were evaluated under different criteria and legal frameworks.
  • Patentability Criteria: Novelty, nonobviousness, and usefulness are key criteria that must be met.
  • Current Landscape: Recent updates and judicial decisions have refined how AI and software-related inventions are evaluated.
  • Practical Implications: Careful claim drafting and understanding of recent case law are crucial for patent eligibility.

Key Takeaways

  • Patent Claims: The structure and language of patent claims are critical in defining the patent's scope.
  • AI and Patent Eligibility: AI-assisted inventions must integrate judicial exceptions into practical applications to be patent-eligible.
  • International Considerations: International patent applications can provide broad protection but come with significant costs.
  • Patent Prosecution: The process can be complex, and innovators must be prepared to argue and amend claims.

FAQs

Q: What are the key criteria for patentability in the United States? A: The key criteria include novelty, nonobviousness, and usefulness.

Q: How has the USPTO guidance update affected AI-related patent applications? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution and the claimed invention offers tangible benefits.

Q: What is the Alice/Mayo test, and how is it used? A: The Alice/Mayo test is a two-step framework used to determine patent eligibility by assessing whether claims are directed to an ineligible concept and whether additional elements transform the concept into patent-eligible subject matter.

Q: What are the benefits and costs of filing an international patent application under the PCT? A: The benefits include preserving the right to file patents in multiple countries, while the costs are significant and often only justified for high-value inventions with near-term global commercial licensing opportunities.

Q: How can practitioners ensure their patent claims meet current eligibility criteria? A: Practitioners should draft claims that integrate judicial exceptions into practical applications, using recent case law and examples provided by the USPTO to demonstrate concrete technological improvements.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Patent-Eligible Subject Matter Reform: An Overview - CRS Reports
  3. Patent Claims and Patent Scope - SSRN
  4. Research and Course Guides: Patent Searching, Advanced: Overview - Clemson University
  5. Intellectual Property Protection - KU Office of Research

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,800,481

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 3,800,481

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 985050 ⤷  Subscribe
United Kingdom 1411518 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.